A 12-week, placebo-controlled study of the efficacy and safety of ebastine, 10 and 20 mg once daily, in the treatment of perennial allergic rhinitis. Multicentre Study Group (Q28141316)
Jump to navigation
Jump to search
scientific article (publication date: June 1999)
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A 12-week, placebo-controlled study of the efficacy and safety of ebastine, 10 and 20 mg once daily, in the treatment of perennial allergic rhinitis. Multicentre Study Group |
scientific article (publication date: June 1999) |
Statements
A 12-week, placebo-controlled study of the efficacy and safety of ebastine, 10 and 20 mg once daily, in the treatment of perennial allergic rhinitis. Multicentre Study Group (English)
0 references
June 1999
0 references
54
0 references
6
0 references
562-8
0 references